Squadron Capital Management LLC
Follow13F filer, CIK 2050709, OAK BROOK, IL
Squadron Capital Management LLC reported $322,245,820 across 43 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 73.03% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002050709-26-000027
- Period
- 2026-06-30
- Reported value
- $322M
- Holdings
- 43
- Top 10 weight
- 73.03%
- New
- 24
- Sold out
- 18
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CCCCadded | +4,950,000 | $23.1M |
| ELVNnew | +160,000 | $8.12M |
| IVAadded | +1,900,000 | $7.18M |
| RLAYadded | +297,500 | $5.57M |
| ADAGnew | +1,250,000 | $5.25M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| KALVexited | -985,100 | -$19.8M |
| ABVXexited | -130,000 | -$14.5M |
| NKTRexited | -125,000 | -$8.99M |
| RLMDreduced | -1,124,571 | -$7.78M |
| SCYXexited | -7,608,695 | -$6.98M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0002050709-26-000027, largest first. % of portfolio is the value over $292,088,707, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RLMDRELMADA THERAPEUTICS INC | 7,350,000 | $50.9M | 17.41% | -1,124,571 | Timeline | ||
| CCCCC4 THERAPEUTICS INC | 7,200,000 | $33.6M | 11.51% | +4,950,000 | Timeline | ||
| COGTCOGENT BIOSCIENCES INC | 865,000 | $33.5M | 11.46% | +77,508 | Timeline | ||
| KODKODIAK SCIENCES INC | 500,000 | $19.5M | 6.67% | +120,000 | Timeline | ||
| RLAYRELAY THERAPEUTICS INC | 970,000 | $18.1M | 6.21% | +297,500 | Timeline | ||
| ZNTLZENTALIS PHARMACEUTICALS INC | 3,700,000 | $17.9M | 6.14% | +69,000 | Timeline | ||
| EWTXEDGEWISE THERAPEUTICS INC | 290,000 | $11.8M | 4.03% | -60,000 | Timeline | ||
| MAZEMAZE THERAPEUTICS INC | 335,000 | $10M | 3.42% | +77,500 | Timeline | ||
| IVAINVENTIVA SA | 2,435,000 | $9.2M | 3.15% | +1,900,000 | Timeline | ||
| ANLADLAI NORTYE GROUP LTD | 764,876 | $8.8M | 3.01% | -500,355 | Timeline | ||
| ELVNENLIVEN THERAPEUTICS INC | 160,000 | $8.12M | 2.78% | new | Timeline | ||
| PALIPALISADE BIO INC | 3,000,000 | $6.27M | 2.15% | 0 | Timeline | ||
| IKTINHIBIKASE THERAPEUTICS INC | 3,000,000 | $6.09M | 2.08% | -500,000 | Timeline | ||
| ADAGADAGENE INC | 1,250,000 | $5.25M | 1.8% | new | Timeline | ||
| FBRXFORTE BIOSCIENCES INC | 225,000 | $4.78M | 1.64% | new | Timeline | ||
| IFRXINFLARX NV | 2,000,000 | $4.48M | 1.53% | new | Timeline | ||
| ASMBASSEMBLY BIOSCIENCES INC | 160,000 | $4.4M | 1.51% | new | Timeline | ||
| PMNPROMIS NEUROSCIENCES INC | 324,977 | $4.28M | 1.46% | 0 | Timeline | ||
| CTNMCONTINEUM THERAPEUTICS INC | 260,000 | $4.26M | 1.46% | new | Timeline | ||
| CMPSCOMPASS PATHWAYS PLC | 300,000 | $4.25M | 1.45% | new | Timeline | ||
| DFTXDEFINIUM THERAPEUTICS INC | 85,000 | $4M | 1.37% | new | Timeline | ||
| SLGLSOL-GEL TECHNOLOGIES LTD | 52,000 | $3.86M | 1.32% | +21,000 | Timeline | ||
| BIOABIOAGE LABS INC | 155,000 | $3.8M | 1.3% | new | Timeline | ||
| SCYXSCYNEXIS INC | 756,884 | $3.08M | 1.05% | new | Timeline | ||
| PRQRPROQR THRAPEUTICS N V | 1,511,496 | $2.81M | 0.96% | new | Timeline | ||
| RZLTREZOLUTE INC | 403,410 | $2.1M | 0.72% | new | Timeline | ||
| LPCNLIPOCINE INC NEW | 810,000 | $2.07M | 0.71% | +360,000 | Timeline | ||
| CUECUE BIOPHARMA INC | 50,000 | $1.58M | 0.54% | new | Timeline | ||
| CALCCALCIMEDICA INC | 1,244,864 | $1.28M | 0.44% | new | Timeline | ||
| QNCXQUINCE THERAPEUTICS INC | 40,375 | $734K | 0.25% | new | Timeline | ||
| KTTAPASITHEA THERAPEUTICS CORP | 1,000,000 | $515K | 0.18% | -1,100,000 | Timeline | ||
| INMINMED PHARMACEUTICALS INC | 325,000 | $504K | 0.17% | new | Timeline | ||
| NMRANEUMORA THERAPEUTICS INC. | 100,000 | $170K | 0.06% | new | Timeline | ||
| NXTCNEXTCURE INC | 64,464 | $103K | 0.04% | -200,536 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| AVBPARRIVENT BIOPHARMA INC COM | call | 183,000 | $6.36M | +73,000 |
| BIOABIOAGE LABS INC Stock | call | 250,000 | $6.13M | new |
| RZLTREZOLUTE INC COMMON STOCK | call | 900,000 | $4.68M | new |
| CMPSCOMPASS PATHWAYS PLC SPONSORED ADS | call | 305,000 | $4.32M | new |
| IRONDISC MEDICINE INC Stock | call | 30,000 | $2.19M | new |
| ZNTLZENTALIS PHARMACEUTICALS INC COMMON STOCK | call | 426,000 | $2.07M | +26,000 |
| CCCCC4 THERAPEUTICS INC COM STK | call | 400,000 | $1.87M | new |
| RAREULTRAGENYX PHARMACEUTICAL IN COM | call | 55,000 | $1.84M | new |
| NVCTNUVECTIS PHARMA INC COMMON STOCK | call | 38,700 | $712K | new |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| KALVKALVISTA PHARMACEUTICALS INC | 985,100 | $19.8M | shares |
| ABVXABIVAX SA | 130,000 | $14.5M | shares |
| NKTRNEKTAR THERAPEUTICS | 125,000 | $8.99M | shares |
| SCYXSCYNEXIS INC | 7,608,695 | $6.98M | shares |
| KALVKALVISTA PHARMACEUTICALS INC | 315,000 | $6.34M | call |
| EPRXEUPRAXIA PHARMACEUTICALS INC | 680,000 | $4.92M | shares |
| GHRSGH RESEARCH PLC | 325,000 | $4.57M | shares |
| KPTIKARYOPHARM THERAPEUTICS INC | 750,000 | $4.18M | put |
| IDYAIDEAYA BIOSCIENCES INC | 120,000 | $4M | put |
| IDYAIDEAYA BIOSCIENCES INC | 104,300 | $3.48M | call |
| ALXOALX ONCOLOGY HLDGS INC | 1,460,000 | $2.93M | shares |
| CNTXCONTEXT THERAPEUTICS INC | 1,100,000 | $2.88M | shares |
| RLAYRELAY THERAPEUTICS INC | 150,000 | $1.49M | call |
| TRAWTRAWS PHARMA INC | 511,714 | $936K | shares |
| TXMDTHERAPEUTICSMD INC | 420,421 | $849K | shares |
| SPRBSPRUCE BIOSCIENCES INC | 12,200 | $797K | shares |
| HOWLWEREWOLF THERAPEUTICS INC | 563,535 | $469K | shares |
| NEUPNEUPHORIA THERAPEUTICS INC | 76,728 | $312K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002050709-26-000027 | base | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002050709-26-000027 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0002050709-26-000017 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0002050709-26-000010 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set |